JP2014520529A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520529A5 JP2014520529A5 JP2014518915A JP2014518915A JP2014520529A5 JP 2014520529 A5 JP2014520529 A5 JP 2014520529A5 JP 2014518915 A JP2014518915 A JP 2014518915A JP 2014518915 A JP2014518915 A JP 2014518915A JP 2014520529 A5 JP2014520529 A5 JP 2014520529A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- mirna
- sample
- level
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091070501 miRNA Proteins 0.000 claims description 145
- 239000002679 microRNA Substances 0.000 claims description 144
- 238000000034 method Methods 0.000 claims description 99
- 108091031326 miR-15b stem-loop Proteins 0.000 claims description 39
- 108091040490 miR-545 stem-loop Proteins 0.000 claims description 38
- 108091029203 miR-301 stem-loop Proteins 0.000 claims description 36
- 108091026505 miR-301a stem-loop Proteins 0.000 claims description 36
- 208000024827 Alzheimer disease Diseases 0.000 claims description 35
- 108091033433 MiR-191 Proteins 0.000 claims description 28
- 108091007427 let-7g Proteins 0.000 claims description 26
- 108091033753 let-7d stem-loop Proteins 0.000 claims description 15
- 108091079658 miR-142-1 stem-loop Proteins 0.000 claims description 12
- 108091071830 miR-142-2 stem-loop Proteins 0.000 claims description 12
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 238000003745 diagnosis Methods 0.000 claims description 5
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 claims description 4
- 230000007423 decrease Effects 0.000 claims description 4
- 229960003530 donepezil Drugs 0.000 claims description 4
- 229960003980 galantamine Drugs 0.000 claims description 4
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 claims description 4
- 108091043994 let-7g stem-loop Proteins 0.000 claims description 4
- 108091053972 let-7g-1 stem-loop Proteins 0.000 claims description 4
- 108091024867 let-7g-2 stem-loop Proteins 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 229960004136 rivastigmine Drugs 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 208000031124 Dementia Alzheimer type Diseases 0.000 claims description 2
- 230000003321 amplification Effects 0.000 claims description 2
- 239000000090 biomarker Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 claims description 2
- 210000002751 lymph Anatomy 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 238000003753 real-time PCR Methods 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 15
- 208000010877 cognitive disease Diseases 0.000 claims 14
- 208000027061 mild cognitive impairment Diseases 0.000 claims 10
- 230000001225 therapeutic effect Effects 0.000 claims 5
- 208000028698 Cognitive impairment Diseases 0.000 claims 4
- 230000002596 correlated effect Effects 0.000 claims 1
- 230000003340 mental effect Effects 0.000 claims 1
- 108091083267 miR-142 stem-loop Proteins 0.000 claims 1
- 108091070626 miR-142a stem-loop Proteins 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 108091007420 miR‐142 Proteins 0.000 description 2
- 230000006996 mental state Effects 0.000 description 1
- 108091069297 miR-35 stem-loop Proteins 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161501720P | 2011-06-27 | 2011-06-27 | |
| US61/501,720 | 2011-06-27 | ||
| PCT/US2012/044202 WO2013003350A2 (en) | 2011-06-27 | 2012-06-26 | Microrna biomarkers indicative of alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016150989A Division JP2016214256A (ja) | 2011-06-27 | 2016-08-01 | アルツハイマー病を示すマイクロｒｎａバイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520529A JP2014520529A (ja) | 2014-08-25 |
| JP2014520529A5 true JP2014520529A5 (enExample) | 2015-08-13 |
| JP6154809B2 JP6154809B2 (ja) | 2017-06-28 |
Family
ID=46724591
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014518915A Active JP6154809B2 (ja) | 2011-06-27 | 2012-06-26 | アルツハイマー病を示すマイクロｒｎａバイオマーカー |
| JP2016150989A Pending JP2016214256A (ja) | 2011-06-27 | 2016-08-01 | アルツハイマー病を示すマイクロｒｎａバイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016150989A Pending JP2016214256A (ja) | 2011-06-27 | 2016-08-01 | アルツハイマー病を示すマイクロｒｎａバイオマーカー |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9771617B2 (enExample) |
| EP (1) | EP2723894B1 (enExample) |
| JP (2) | JP6154809B2 (enExample) |
| KR (1) | KR102082016B1 (enExample) |
| CN (1) | CN103781919B9 (enExample) |
| AU (1) | AU2012275556B2 (enExample) |
| BR (1) | BR112013033488B8 (enExample) |
| CA (1) | CA2840196C (enExample) |
| ES (1) | ES2580379T3 (enExample) |
| IL (1) | IL230034B (enExample) |
| MX (1) | MX341840B (enExample) |
| RU (1) | RU2639509C2 (enExample) |
| WO (1) | WO2013003350A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013022953A2 (en) * | 2011-08-08 | 2013-02-14 | Eugenia Wang | Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof |
| WO2015050835A1 (en) * | 2013-10-01 | 2015-04-09 | Advanced Genomic Technology, Llc | Circulating biomarkers for alzheimer's disease and/or mild cognitive impairment |
| WO2015134551A1 (en) * | 2014-03-03 | 2015-09-11 | Banyan Biomarkers, Inc. | Micro rna markers for diagnosis of a neurological condition |
| KR101583450B1 (ko) * | 2014-12-01 | 2016-01-11 | 전주대학교 산학협력단 | 마이크로 rna id의 분석방법 및 이를 통해 도출한 대장암의 바이오마커 |
| ES2894875T3 (es) | 2015-03-13 | 2022-02-16 | Univ Hiroshima | Método para ayudar a la detección de la enfermedad de Alzheimer o de una discapacidad cognitiva moderada |
| US10358676B2 (en) * | 2015-04-03 | 2019-07-23 | Kaohsiung Chang Gung Memorial Hospital | Methods and kits for detecting Kawasaki disease |
| KR101734645B1 (ko) * | 2015-05-18 | 2017-05-11 | (주)에이엔티랩스 | 초기 알츠하이머 병 또는 경도 인지 장애 진단 방법 |
| EP4424704A3 (en) | 2015-09-16 | 2024-12-25 | Shimadzu Corporation | Multiplex biomarker for use in evaluation of state of accumulation of amyloid b in brain, and analysis method for said evaluation |
| ES2734678T3 (es) * | 2015-12-22 | 2019-12-11 | Siemens Ag | Firmas específicas en enfermedad de alzheimer por perfiles de miarn multicéntricos |
| US10262423B2 (en) * | 2016-03-29 | 2019-04-16 | Verily Life Sciences Llc | Disease and fall risk assessment using depth mapping systems |
| WO2017186719A1 (en) * | 2016-04-25 | 2017-11-02 | Instytut Biologii Doswiadczalnej Im. Marcelego Nenckiego Polska Akademia Nauk | Microrna biomarkers in blood for diagnosis of alzheimer's disease |
| KR101998457B1 (ko) * | 2016-05-10 | 2019-07-10 | 조선대학교산학협력단 | 알츠하이머 질병의 진단을 위한 바이오마커 |
| KR101992539B1 (ko) * | 2016-10-21 | 2019-09-30 | 서울대학교산학협력단 | miRNA 기반의 인지장애 질환 진단용 조성물 및 방법 |
| WO2018228875A1 (en) * | 2017-06-15 | 2018-12-20 | Nestec S.A. | Micro-rna biomarkers of blood-brain barrier dysfunction |
| WO2018236589A1 (en) * | 2017-06-19 | 2018-12-27 | St. John's University | CIRCULATING SERIES MICRO-RNA BIOMARKERS AND METHODS OF DIAGNOSING ALZHEIMER'S DISEASE |
| AU2018300159A1 (en) * | 2017-07-12 | 2020-02-06 | Texas Tech University System | MicroRNA-455-3p as a peripheral biomarker for Alzheimer's disease |
| US11078535B2 (en) * | 2017-07-18 | 2021-08-03 | The Trustees Of Indiana University | Presymptomatic micro RNA targets for treatment of neurodegeneration pathology |
| WO2019081497A1 (en) * | 2017-10-25 | 2019-05-02 | Hummingbird Diagnostics Gmbh | MIARN AS BIOMARKERS OF ALZHEIMER'S DISEASE |
| EP3707259A4 (en) * | 2017-11-12 | 2021-08-11 | The Regents of the University of California | NON-CODING RNA FOR CANCER DETECTION |
| WO2019117306A1 (ja) | 2017-12-14 | 2019-06-20 | 国立大学法人広島大学 | アルツハイマー病の検出を補助する方法 |
| CN108277271A (zh) * | 2018-02-05 | 2018-07-13 | 范瑶飞 | 一种辅助检测阿兹海默疾病的miRNA |
| EP4697021A3 (en) * | 2018-02-13 | 2026-05-20 | Toray Industries | DEMENTIA DETECTION KIT OR DEVICE AND METHOD |
| EP3807422B1 (en) | 2018-06-15 | 2025-12-03 | Universitat Autònoma de Barcelona | Circulating mirnas as biomarkers for diagnosis of mild cognitive impairment and alzheimer´s disease |
| US20210292840A1 (en) * | 2018-07-25 | 2021-09-23 | Srnalytics, Inc. | Small rna predictors for alzheimer's disease |
| JP6884810B2 (ja) * | 2019-05-08 | 2021-06-09 | キユーピー株式会社 | 情報提供装置、情報提供方法及びｍｉＲＮＡ重要度テーブル生成方法 |
| US20240093297A1 (en) * | 2020-07-24 | 2024-03-21 | Otago Innovation Limited | Biomarkers For Cognitive Conditions |
| WO2022165205A1 (en) * | 2021-01-29 | 2022-08-04 | Arizona Board Of Regents On Behalf Of Arizona State University | Systems and methods for diagnosing neurodegenerative diseases |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
| US5965364A (en) | 1990-10-09 | 1999-10-12 | Benner; Steven Albert | Method for selecting functional deoxyribonucleotide derivatives |
| US5767259A (en) | 1994-12-27 | 1998-06-16 | Naxcor | Oligonucleotides containing base-free linking groups with photoactivatable side chains |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| AU713667B2 (en) | 1996-04-12 | 1999-12-09 | Phri Properties, Inc. | Detection probes, kits and assays |
| SE506700C2 (sv) | 1996-05-31 | 1998-02-02 | Mikael Kubista | Sond och förfaranden för analys av nukleinsyra |
| US6485901B1 (en) | 1997-10-27 | 2002-11-26 | Boston Probes, Inc. | Methods, kits and compositions pertaining to linear beacons |
| US6355421B1 (en) | 1997-10-27 | 2002-03-12 | Boston Probes, Inc. | Methods, kits and compositions pertaining to PNA molecular beacons |
| US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| US6383752B1 (en) | 1999-03-31 | 2002-05-07 | Hybridon, Inc. | Pseudo-cyclic oligonucleobases |
| WO2001031580A2 (en) | 1999-10-27 | 2001-05-03 | Biowulf Technologies, Llc | Methods and devices for identifying patterns in biological systems |
| US6528254B1 (en) | 1999-10-29 | 2003-03-04 | Stratagene | Methods for detection of a target nucleic acid sequence |
| US6596490B2 (en) | 2000-07-14 | 2003-07-22 | Applied Gene Technologies, Inc. | Nucleic acid hairpin probes and uses thereof |
| AU2001280581A1 (en) | 2000-07-18 | 2002-01-30 | Correlogic Systems, Inc. | A process for discriminating between biological states based on hidden patterns from biological data |
| US6350580B1 (en) | 2000-10-11 | 2002-02-26 | Stratagene | Methods for detection of a target nucleic acid using a probe comprising secondary structure |
| US7113896B2 (en) | 2001-05-11 | 2006-09-26 | Zhen Zhang | System and methods for processing biological expression data |
| WO2003020739A2 (en) | 2001-09-04 | 2003-03-13 | Exiqon A/S | Novel lna compositions and uses thereof |
| US6593091B2 (en) | 2001-09-24 | 2003-07-15 | Beckman Coulter, Inc. | Oligonucleotide probes for detecting nucleic acids through changes in flourescence resonance energy transfer |
| US20020193950A1 (en) | 2002-02-25 | 2002-12-19 | Gavin Edward J. | Method for analyzing mass spectra |
| US20030225031A1 (en) * | 2002-05-21 | 2003-12-04 | Quay Steven C. | Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| JP2004161636A (ja) | 2002-11-11 | 2004-06-10 | Takeda Chem Ind Ltd | 軽度認知障害または注意欠陥多動性障害治療剤 |
| US7291488B2 (en) | 2003-04-25 | 2007-11-06 | Becton, Dickinson & Company | Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
| US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
| EP2272987A3 (en) | 2004-07-09 | 2012-04-11 | University of Pittsburgh of the Commonwealth System of Higher Education | Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma |
| US20060078894A1 (en) | 2004-10-12 | 2006-04-13 | Winkler Matthew M | Methods and compositions for analyzing nucleic acids |
| JP2006176503A (ja) * | 2004-11-26 | 2006-07-06 | Tohoku Univ | 脳血管障害を伴うアルツハイマー病治療薬 |
| RU2418068C2 (ru) * | 2005-08-17 | 2011-05-10 | Сирна Терапьютикс, Инк. | Молекулы химически модифицированной короткой интерферирующей нуклеиновой кислоты, которые опосредуют интерференцию рнк |
| WO2007044937A2 (en) * | 2005-10-13 | 2007-04-19 | President And Fellows Of Harvard College | Compositions and methods to modulate memory |
| MX2009001937A (es) * | 2006-08-21 | 2009-04-30 | Novartis Ag | Biomarcadores para el progreso de la enfermedad de alzheimer. |
| WO2008153692A2 (en) * | 2007-05-22 | 2008-12-18 | The Brigham And Women's Hospital, Inc. | Microrna expression profiling of cerebrospinal fluid |
| EP2160477B1 (en) * | 2007-05-23 | 2013-08-07 | Dharmacon, Inc. | Micro-RNA scaffolds and non-naturally occurring micro-RNAs |
| US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
| WO2009009439A2 (en) | 2007-07-06 | 2009-01-15 | The Regents Of The University Of California | Snps associated with fatty acid composition of bovine meat and milk |
| WO2009009457A1 (en) * | 2007-07-06 | 2009-01-15 | University Of Louisville Research Foundation, Inc. | Alzheimer's disease-specific micro-rna microarray and related methods |
| EP2613149B1 (en) | 2007-07-25 | 2014-09-17 | University Of Louisville Research Foundation, Inc. | Exosome-associated microRNA as a diagnostic marker |
| SI2182983T1 (sl) | 2007-07-27 | 2014-09-30 | Janssen Alzheimer Immunotherapy | Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta |
| ES2660785T3 (es) | 2007-08-22 | 2018-03-26 | Trovagene, Inc. | Métodos de uso de ARNmi para la detección de la muerte de células in vivo |
| EP2610342B1 (en) * | 2007-09-14 | 2016-05-04 | The Ohio State University Research Foundation | MiRNA Expression in Human Peripheral Blood Microvesicles and uses Thereof |
| CA2709354C (en) | 2007-12-21 | 2014-06-17 | Amgen Inc. | Anti-amyloid antibodies and uses thereof |
| WO2009143379A2 (en) | 2008-05-21 | 2009-11-26 | Fred Hutchinson Cancer Research Center | Use of extracellular rna to measure disease |
| CN101386848A (zh) * | 2008-08-12 | 2009-03-18 | 南京大学 | 细胞微粒子所载微小核糖核酸及其制备研究方法和应用 |
| CA2743211A1 (en) * | 2008-11-12 | 2010-05-20 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods and systems of using exosomes for determining phenotypes |
| US8637525B2 (en) | 2009-07-31 | 2014-01-28 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
| EP2287336A1 (fr) | 2009-07-31 | 2011-02-23 | Exhonit Therapeutics SA | Procédés et méthodes de diagnostic de la maladie d'Alzheimer |
| WO2011029903A1 (en) | 2009-09-10 | 2011-03-17 | Flemming Velin | Method for the preparation of micro-rna and its therapeutic application |
| ES2597554T3 (es) | 2009-11-04 | 2017-01-19 | Diamir, Llc | Métodos de utilización de micro-ARN de fluidos corporales para el diagnóstico y control del deterioro cognitivo leve |
| GB201011420D0 (en) | 2010-07-06 | 2010-08-18 | United Arab Emirates Universit | Method for diagnosis |
| NZ606848A (en) | 2010-09-22 | 2015-01-30 | Janssen Pharmaceutica Nv | 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace) |
| KR20140024270A (ko) | 2010-12-30 | 2014-02-28 | 파운데이션 메디신 인코포레이티드 | 종양 샘플의 다유전자 분석의 최적화 |
| US8945829B2 (en) | 2011-03-22 | 2015-02-03 | Cornell University | Distinguishing benign and malignant indeterminate thyroid lesions |
| US9023359B1 (en) | 2014-07-15 | 2015-05-05 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
-
2012
- 2012-06-26 JP JP2014518915A patent/JP6154809B2/ja active Active
- 2012-06-26 AU AU2012275556A patent/AU2012275556B2/en active Active
- 2012-06-26 EP EP12750628.5A patent/EP2723894B1/en active Active
- 2012-06-26 RU RU2014102357A patent/RU2639509C2/ru active
- 2012-06-26 KR KR1020147001923A patent/KR102082016B1/ko active Active
- 2012-06-26 CA CA2840196A patent/CA2840196C/en active Active
- 2012-06-26 US US14/128,888 patent/US9771617B2/en active Active
- 2012-06-26 WO PCT/US2012/044202 patent/WO2013003350A2/en not_active Ceased
- 2012-06-26 BR BR112013033488A patent/BR112013033488B8/pt active IP Right Grant
- 2012-06-26 MX MX2013015392A patent/MX341840B/es active IP Right Grant
- 2012-06-26 CN CN201280041358.8A patent/CN103781919B9/zh active Active
- 2012-06-26 ES ES12750628.5T patent/ES2580379T3/es active Active
-
2013
- 2013-12-19 IL IL230034A patent/IL230034B/en active IP Right Grant
-
2016
- 2016-08-01 JP JP2016150989A patent/JP2016214256A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014102357A (ru) | МикроРНК-БИОМАРКЕРЫ, УКАЗЫВАЮЩИЕ НА БОЛЕЗНЬ АЛЬЦГЕЙМЕРА | |
| Correia et al. | Circulating microRNAs as potential biomarkers of infectious disease | |
| Chen et al. | MicroRNAs as biomarkers of resilience or vulnerability to stress | |
| CN103620057B (zh) | 使用来自体液的miRNA来早期检测和监控轻度认知障碍(MCI)和阿尔茨海默病(AD)的方法 | |
| EP2559773B1 (en) | Methods for determining a hepatocellular carcinoma subtype | |
| JP2019528081A5 (enExample) | ||
| EP2364367A2 (en) | Methods, compositions, and devices utilizing microrna to determine physiological conditions | |
| CA2812940A1 (en) | Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease | |
| CA2679784A1 (en) | Diagnostic, prognostic and treatment methods | |
| EP3026121A1 (en) | Micro-RNA-based diagnosis of tuberculosis | |
| JP2021112167A (ja) | うつ病の診断補助方法及び診断用キット | |
| US20180044733A1 (en) | Circulatory MicroRNAs (miRNAs) as Biomarkers for Diabetic Retinopathy (DR) and Age-Related Macular Degeneration | |
| Villareal et al. | Deterioration of neuroimmune homeostasis in Alzheimer’s Disease patients who survive a COVID-19 infection | |
| CN104232636A (zh) | 乙型肝炎microRNA分子标志物组合及其用途 | |
| JP2018522558A (ja) | 外傷性脳損傷のためのマイクロｒｎａバイオマーカー、及びその使用方法 | |
| Vistbakka et al. | Temporal variability of serum miR-191, miR-223, miR-128, and miR-24 in multiple sclerosis: A 4-year follow-up study | |
| JP2014064570A (ja) | 組織傷害あるいは細胞増殖性疾患の検出方法 | |
| Cheong et al. | Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma | |
| WO2018159750A1 (ja) | オピオイド薬の治療有効性を予測するためのｍｉｃｒｏＲＮＡバイオマーカー | |
| CN110527721B (zh) | 一种陈旧性结核病标志物及其应用 | |
| JP2017512204A5 (enExample) | ||
| EP4185713A1 (en) | Biomarkers for cognitive conditions | |
| JPWO2011027893A1 (ja) | 慢性ｃ型肝炎の治療効果予測方法 | |
| JP6156621B2 (ja) | Ａｔｌｌの診断のためのデータ取得方法、ａｔｌｌ診断用キットおよびａｔｌｌ診断システム | |
| CN107557464A (zh) | 用于干扰素治疗慢性乙型肝炎早期病毒学反应的预测模型及检测试剂盒 |